Illumina Acquires Edico Genome

May 15, 2018

|

NEW YORK (GenomeWeb) – Illlumina said today that it has acquired data analysis firm Edico Genome.

Edico markets its DRAGEN platform, which uses field programmable gate array technology in combination with proprietary software algorithms to reduce data footprint and enable faster speeds. Users can run DRAGEN on site, in the cloud or in a hybrid mode, and can use a variety of different cloud storage solutions and analysis pipelines.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Move Away From Basic Research?

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.

Noel Rose Dies

Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.

Flush the System

According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.

PLOS Papers on Malaria in Southeast Asia, Yellow Fever in Brazil, Dengue Virus Genotyping

In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.

Featured White Papers

Compatibility of liquid biopsy assays on multiple sequencing platforms

Delivering Rapid Whole Genome Reports for ICU Cases with Opal Clinical STAT

White Paper: Using Single-Cell Multiomics to Reveal New Insights Into Uveal Melanoma Evolution and Therapeutic Resistance

AnyDeplete - A customizable depletion solution for RNA-Seq workflows

Aug

13

Featured Webinar

Single-Cell and Spatial Transcriptomic Profiling of the Septic Kidney

This webinar will discuss a study that combined single-cell gene expression and spatial gene expression to understand the evolution of sepsis in the kidney at the cellular and molecular level.

Aug

18

Featured Webinar

COVID-19 Wastewater-Based Epidemiology: Methods and Insights for SARS-CoV-2 Community Surveillance

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Aug

24

Featured Webinar

Utility of Novel RNA-Based Tools in Oncology Drug Development

This webinar, Part 1 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss how gene expression signatures can accelerate (and rehabilitate) drug programs, define targeted patient populations, expand drug indications, and improve clinical success.

Aug

26

Featured Webinar

Resolving Complex Haplotypes Implicated in Alzheimer’s and Other Neurodegenerative Diseases

Alzheimer’s disease is genetically complex with no meaningful therapies or pre-symptomatic disease diagnostics.

Menu

Illumina Acquires Edico Genome

To read the full story....

Breaking News

NanoString Q2 Revenues Drop 25 Percent But Beat Street Estimates

Adaptive Biotechnologies Q2 Revenues Fall 5 Percent, Beat Analyst Estimates

Castle Biosciences Q2 Revenues Up 18 Percent

HTG Molecular Diagnostics, Qiagen Ink CDx Commercialization, Distribution Agreement

T Cell Receptor Repertoire Linked to Anti-PD-1 Therapy Response in Hodgkin Lymphoma

Autism Subtype Marked by Abnormal Lipid Levels Uncovered in Analysis of Research, Healthcare Data

The Scan

Move Away From Basic Research?

Noel Rose Dies

Flush the System

PLOS Papers on Malaria in Southeast Asia, Yellow Fever in Brazil, Dengue Virus Genotyping

Featured White Papers

Single-Cell and Spatial Transcriptomic Profiling of the Septic Kidney

COVID-19 Wastewater-Based Epidemiology: Methods and Insights for SARS-CoV-2 Community Surveillance

Utility of Novel RNA-Based Tools in Oncology Drug Development

Resolving Complex Haplotypes Implicated in Alzheimer’s and Other Neurodegenerative Diseases

What's Popular?

Helix Gets FDA Emergency Use Authorization for NGS-Based COVID-19 Test

Illumina Sees Expanding Sequencing Market in COVID-19 Response, Despite Short-Term Woes

Illumina Q2 Revenues Drop 25 Percent

Newborn Exome Sequencing Shows Potential to Help Find Inborn Errors of Metabolism

Blackstone to Acquire Ancestry for $4.7B

Sponsorships